Broadridge Financial Solutions, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 3, 2026, reporting first-quarter fiscal 2027 financial results including revenues of $1,668.7 million and net earnings of $94.8 million.
Strata Critical Medical, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss from continuing operations of $7,615 thousand for the three months ended September 30, 2026.
Charles R. Schwab, officer and director of The Charles Schwab Corporation, filed a Form 144 notice on November 3, 2026, proposing to sell 11,675 shares of common stock held through the Helen Schwab 2016 GRAT II Trust FBO Matthew C. Paige.
Matthew J. Cornell, Chief Financial Officer of Hyster-Yale, Inc., filed a Form 4 on November 3, 2026, disclosing the acquisition of 3,500 shares of Class A Common Stock on November 2, 2026, at a price of $0 under the company's Supplemental Long-Term Equity Incentive …
Christina Schelling, EVP and Chief People Officer of Verizon Communications Inc., filed a Form 4 on November 3, 2026, disclosing the acquisition of 11,179 Restricted Stock Units under a 2026 Promotional Award granted on November 1, 2026.
Mark Earl Hensley, Chief Operating Officer of Heron Therapeutics, Inc. /DE/ (NASDAQ:HRTX), filed a Form 4 on November 3, 2026, reporting a restricted stock unit vesting and a related tax-withholding disposition of common stock on October 30, 2026.
Christina Schelling, Executive Vice President and Chief People Officer of Verizon Communications Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 3, 2026, with a triggering event date of November 1, 2026.
Director Mary Tuuk Kuras filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 406 shares of UFP Industries Inc common stock on November 2, 2026.
Barclays PLC filed a Form 6-K on November 3, 2026, disclosing that Group Chief Risk Officer Taalib Shaah acquired 9,512 ordinary shares on November 2, 2026, following the exercise of an option under the Barclays Group SAYE Share Option Scheme.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,884 on November 3, 2026, describing Market Linked Securities that are auto-callable with contingent downside and linked to the lowest performing of three S&P indexes, maturing May 7, 2032.